- Report ID: BMRC 276 | Number of pages: 200 | Publish Date: Dec 2019
Status: Published | Category: Healthcare | Delivery Timeline:
Vaccines Market: Rising burden of several infectious and non-infectious diseases, increasing government and non government support for vaccine development, and increasing Research and Underdevelopment likely to augment the growth of Global Vaccine Market.
A vaccine is a biological preparationwhich is administered to produceactive acquired immunity for particular disease and it is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called as “Vaccination” which aids to increase the immune response against a specific pathogen.Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine uses that ability of the body to enable it to defend itself from those microorganisms which have attacked it earlier. Usually vaccines are administered through injections, orally and sprayed into the nose.Vaccines can be divides into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.
The Global Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc.The demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases. Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout lifespan and gives protection against different types of infectious diseases.Vaccine technology is procedure to observe a revolution. As a more understanding of the human immune system’s protective antibody and cell-based responses to foreign antigens will causes the development of advanced diagnostics and improvement of therapeutic applications. As further governments across the
World identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Certain increasing demand worldwide and currently-unmet needs, the Global Vaccination Market has substantial potential for technological novelty and revenue growth.Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection. The increasing popularity of pediatric, travel, addiction and pediatric combination vaccines the newly developed vaccines that are safer and more effective, better public awareness, technological advancements in molecular genetics area and the adoption of novel vaccine delivery mechanisms are chiefly driving the growth of the global vaccination market. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boost the Global Vaccine Market growth.
Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover additional 1.5 million deaths could be avoided due to enhanced global vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its global usage in the upcoming future.
Global Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of TechnologyGlobal Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines,Inactivated Vaccines Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of IndicationGlobal Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User Global Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.
The regions covered in Global Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Vaccines Market reports cover prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Bavarian Nordic,Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb,Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc.,Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd.,Janssen Pharmaceutical Company,Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai,Hissen andJintan.
Global Vaccines Market Dynamics –
The rise in acceptance of pediatrics, travel, addiction, and pediatric combination vaccines also recently developed vaccines that are safer and more effective, better, public awareness, technological advancements in molecular genetics area and the acceptance of new vaccine delivery mechanisms are mainly driving the growth of the Global Vaccination Market. Rise inincidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well asGovernment initiatives for expanding vaccination coverage are likely to boost the demand for vaccines globally. The Government of Asian country launched the ‘Pan-India campaign for contagious disease-Rubella Vaccination’ in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles.This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years and increasing investments by companies are driving the vaccine market.Excessive cost related with storage and transportation of vaccines will restrain the Global Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the Global Vaccine Market expansion over the coming years. Crucial problems in the Global Vaccine Market now a days are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems.
By End User
Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Interested in this report?
Vaccines Market Size: By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Indication (Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Hepatitis ), By End User (Pediatric Vaccines, Adult Vaccines, Traveller Vaccines), Industry Analysis, Trends, and Forecast 2020-2025